NCT05794646View on ClinicalTrials.gov

Community Intervention to Eliminate HCV Among People Who Use Drugs.

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,400

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

May 16, 2025

Study Completion Date

September 30, 2025

Conditions
HCVSubstance Use Disorders
Interventions
OTHER

Hybrid effectiveness-implementation study type 2

Diagnosis of hepatitis C; Assessment of hepatic fibrosis; Treatment of hepatitis C; Assessment of psychological disorders and treatment or referral.

Trial Locations (4)

13000

Marseille, Marseille

69000

Lyon, Lyon

75000

Paris, Paris

97200

Martinique, Fort-de-France

All Listed Sponsors
lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT05794646 - Community Intervention to Eliminate HCV Among People Who Use Drugs. | Biotech Hunter | Biotech Hunter